Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$22.19 USD
+0.27 (1.23%)
Updated May 31, 2024 04:00 PM ET
After-Market: $22.21 +0.02 (0.09%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Bicycle Therapeutics PLC Sponsored ADR [BCYC]
Reports for Purchase
Showing records 81 - 100 ( 101 total )
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
See Our Highlights from AACR II (June 22-24, 2020) Meeting Abstracts
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Healthcare-Check Out Our Highlights From 2020 ASCO Abstracts
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
"Consider Reading" Vol. 15: MMAE Delivery into Tumors Using a Bicyclic Peptide
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Reminder to Register for Our ASCO Abstract Titles Webinar
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Register for Our Webinar: ACSO Abstract Titles Review '-' April 30th at 10am ET
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
From ADC to BTC, Pedaling Toxins Deep Into the Tumor; Initiating With a Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Expanding Footprint in Immuno- Oncology With Genentech Partnership
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
New Collaboration with CRUK to Develop Multivalent CD137 Agonist
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Bicycle Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key 2020 Events To Advance More Bicycles In Clinic
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T